The effect of melatonin on spinal cord after ischemia in rats

Study design: Experimental animal model to assess ischemic spinal cord injury (SCI) following occlusion of the thoraco-abdominal aorta. Objectives: In the present study, we aimed to investigate the role of melatonin on SCI induced by ischemia and following reperfusion. Setting: Animal Research Labor...

Full description

Saved in:
Bibliographic Details
Published in:Spinal cord 2016-05, Vol.54 (5), p.360-363
Main Authors: Aydemir, S, Dogan, D, Kocak, A, Dilsiz, N
Format: Article
Language:English
Subjects:
13
13/2
631/378
692/617
82
82/80
Anatomy
Animals
Antioxidants - therapeutic use
Biomedical and Life Sciences
Biomedicine
Caspase 3 - metabolism
Disease Models, Animal
Gene Expression Regulation - drug effects
Glutathione - metabolism
Human Physiology
Malondialdehyde - metabolism
Melatonin - therapeutic use
Neurochemistry
Neuropsychology
Neurosciences
original-article
Rats
Reperfusion
Spinal Cord - metabolism
Spinal Cord - pathology
Spinal Cord Ischemia - drug therapy
Statistics, Nonparametric
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Study design: Experimental animal model to assess ischemic spinal cord injury (SCI) following occlusion of the thoraco-abdominal aorta. Objectives: In the present study, we aimed to investigate the role of melatonin on SCI induced by ischemia and following reperfusion. Setting: Animal Research Laboratory, Inonu University, Malatya, Turkey. Methods: We evaluated oxidative damage and caspase-3 activity. In total, 32 adult Wistar albino rats were divided into four groups: Group 1, control ( n =8); Group 2 ( n =8), those subjected to ischemia/reperfusion (IR) by clamping the thoraco-abdominal aorta; Group 3 ( n =8), melatonin (50 mg kg −1 ) treated; and Group 4 ( n =8), melatonin (50 mg kg −1 ) followed by ischemia. All animals were kept alive for 48 h, and then spinal cord samples were removed. We assayed oxidative damage by measuring malondialdehyde (MDA), apoptosis by measuring activated caspase-3 (using immunoblots) and intrinsic antioxidative capacity by measuring reduced glutathione (GSH) levels in the spinal cord. Results: The results indicated a significant decrease in activity of caspase-3 in SCI animals after treatment with melatonin, as it significantly decreased the formation of MDA and decelerated the loss of GSH. Conclusion: This study suggested that melatonin could be an effective neuroprotective agent for treatment of SCI.
ISSN:1362-4393
1476-5624
DOI:10.1038/sc.2015.204